CONTINGENT VALUE RIGHTS AGREEMENTContingent Value Rights Agreement • December 31st, 2019 • Gemphire Therapeutics Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledDecember 31st, 2019 Company Industry JurisdictionThis CONTINGENT VALUE RIGHTS AGREEMENT (this “Agreement”), dated as of December 30, 2019 (the “Effective Date”), is entered into by and among Gemphire Therapeutics Inc., a Delaware corporation (“Parent”), Grand Rapids Holders’ Representative, LLC, as representative of the Holders (the “Holders’ Representative”), and Computershare Inc., as Rights Agent.
CONTINGENT VALUE RIGHTS AGREEMENTContingent Value Rights Agreement • July 25th, 2019 • Gemphire Therapeutics Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledJuly 25th, 2019 Company Industry JurisdictionThis CONTINGENT VALUE RIGHTS AGREEMENT (this “Agreement”), dated as of --, 2019 (the “Effective Date”), is entered into by and among Gemphire Therapeutics Inc., a Delaware corporation (“Parent”), Grand Rapids Holders’ Representative, LLC, as representative of the Holders (the “Holders’ Representative”), and Computershare Inc., as Rights Agent.